Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony V Moorman

Showing results (71-80 of 155) with videos related to

Pageof 16
Sort By:
Blood Advances|December 19, 2023
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative studyAmir Enshaei, Melvin Joy, Ellie Butler, et al.
Leukemia|June 6, 2024
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?Anna Østergaard, Marta Fiocco, Hester de Groot-Kruseman, et al.
British Journal of Haematology|March 29, 2022
Activity and toxicity of intramuscular 1000 iu/m<sup>2</sup> polyethylene glycol-E. coli L-asparaginase in the UKALL 2003 and UKALL 2011 clinical trialsJasmeet Sidhu, Ashish Narayan Masurekar, Manash Pratim Gogoi, et al.
British Journal of Haematology|March 14, 2012
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trialJonathan I Sive, Georgina Buck, Adele Fielding, et al.
Leukemia|January 20, 2023
Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemiaPaul B Sinclair, Ruth E Cranston, Prahlad Raninga, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2008
Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancerQian An, Sarah L Wright, Zoë J Konn, et al.
The Lancet. Oncology|July 11, 2014
Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trialsRobert K Hills, Sylvie Castaigne, Frederick R Appelbaum, et al.
Leukemia|September 29, 2023
Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platformAmir Enshaei, Javier Martinez Elicegui, Esther Anguiano, et al.
Blood|February 14, 2016
EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implicationsClaire Schwab, Sarra L Ryan, Lucy Chilton, et al.
Genes, Chromosomes & Cancer|September 4, 2008
The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1Helen Parker, Qian An, Kerry Barber, et al.
Pageof 16

Showing results (71-80 of 155) with videos related to

Sort By:
Pageof 16
Blood Advances|December 19, 2023
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative studyAmir Enshaei, Melvin Joy, Ellie Butler, et al.
Leukemia|June 6, 2024
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?Anna Østergaard, Marta Fiocco, Hester de Groot-Kruseman, et al.
British Journal of Haematology|March 29, 2022
Activity and toxicity of intramuscular 1000 iu/m<sup>2</sup> polyethylene glycol-E. coli L-asparaginase in the UKALL 2003 and UKALL 2011 clinical trialsJasmeet Sidhu, Ashish Narayan Masurekar, Manash Pratim Gogoi, et al.
British Journal of Haematology|March 14, 2012
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trialJonathan I Sive, Georgina Buck, Adele Fielding, et al.
Leukemia|January 20, 2023
Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemiaPaul B Sinclair, Ruth E Cranston, Prahlad Raninga, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2008
Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancerQian An, Sarah L Wright, Zoë J Konn, et al.
The Lancet. Oncology|July 11, 2014
Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trialsRobert K Hills, Sylvie Castaigne, Frederick R Appelbaum, et al.
Leukemia|September 29, 2023
Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platformAmir Enshaei, Javier Martinez Elicegui, Esther Anguiano, et al.
Blood|February 14, 2016
EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implicationsClaire Schwab, Sarra L Ryan, Lucy Chilton, et al.
Genes, Chromosomes & Cancer|September 4, 2008
The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1Helen Parker, Qian An, Kerry Barber, et al.
Pageof 16